TUDOR INVESTMENT CORP ET AL - IMMUNOCELLULAR THERAPEUTICS ownership

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of IMMUNOCELLULAR THERAPEUTICS
ValueSharesWeighting
Q3 2014$45,0000.0%50,124
+23.6%
0.00%0.0%
Q2 2014$45,000
-8.2%
40,5690.0%0.00%0.0%
Q1 2014$49,000
-19.7%
40,569
-38.8%
0.00%
-33.3%
Q4 2013$61,00066,3030.00%
Other shareholders

There were no reported owners of IMMUNOCELLULAR THERAPEUTICS in Q3 2023.

NameSharesValueWeighting ↓
View complete list of IMMUNOCELLULAR THERAPEUTICS shareholders